Researchers are on a mission to identify blood-borne biomarkers for dementia. Will this year’s high-profile successes pave the way?
In a study appearing this month (July 8) in Alzheimer’s & Dementia, Simon Lovestone of King’s College London and University of Oxford and his colleagues published on a panel of 10 proteins that could predict progression from mild cognitive impairment (MCI) to full-blown Alzheimer’s with a reported accuracy of 87 percent (calculated as the total number of true results, both positives and negatives, over the total number of tests given).
Alzheimer’s in the Blood
Source: The Scientist Magazine®